Publications by authors named "Nancy Tich"

Claim this Profile
L
Long-term safety and tolerability of transdermal cannabidiol gel in children and adolescents with Fragile X syndrome (ZYN2-CL-017): an interim analysis of an ongoing open-label extension study.
Elizabeth Berry-Kravis, Randi Hagerman, Jonathan Cohen, Dejan Budimirovic, Caroline B Buchanan, Nancy Tich

J Neurodev Disord· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A randomized, controlled trial of ZYN002 cannabidiol transdermal gel in children and adolescents with fragile X syndrome (CONNECT-FX).
Elizabeth Berry-Kravis, Randi Hagerman, Dejan Budimirovic, Craig Erickson, Helen Heussler, Nancy Tich

J Neurodev Disord· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A phase 1/2, open-label assessment of the safety, tolerability, and efficacy of transdermal cannabidiol (ZYN002) for the treatment of pediatric fragile X syndrome.
Helen Heussler, Jonathan Cohen, Natalie Silove, Nancy Tich, Marcel O Bonn-Miller

J Neurodev Disord· August 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis